Health care product with effect of protecting liver

Abstract

The invention discloses a health care product with the effect of protecting liver, which is characterized by being prepared from the following raw materials in part by weight: 10 to 20 parts of kudzuvine root, 10 to 20 parts of tangerine peel, 10 to 25 parts of red jujube, 10 to 20 parts of Siberian solomonseal rhizome, 10 to 20 parts of virgate wormwood herb, 10 to 20 parts of white paeony root, 5 to 10 parts of cassia seed, 10 to 20 parts of Chinese magnoliavine fruit, 10 to 20 parts of roasted liquoric root, 10 to 20 parts of Chinese wolfberry, 10 to 20 parts of cinnamomvine, 10 to 20 parts of large-flowered purslane, 10 to 20 parts of bupleurum, 10 to 20 parts of pilose asiabell root, 10 to 20 parts of poria, 10 to 15 parts of pearl, 10 to 20 parts of mulberry, 10 to 20 parts of tuber fleeceflower root, 10 to 20 parts of largehead atractylodes rhizome, 10 to 20 parts of root of red-rooted salvia, 15 to 25 parts of Chinese angelica, 10 to 20 parts of baical skullcap root, 10 to 20 parts of common macrocarpium fruit and 20 to 30 parts of xylooligosaccharide. The health care product has the advantages of improving the immunity of human bodies, improving the function of the liver, promoting the regeneration of liver cells, enhancing the detoxication capability of the liver, and not producing negative effects if taken for long time.

Description

technical field [0001] The invention relates to a health care product, in particular to a health care product with functions of protecting the liver. Background technique [0002] At present, viral hepatitis, alcohol and drug poisoning liver disease, liver damage caused by systemic diseases and subsequent liver fibrosis, liver cirrhosis, liver failure, etc., have become the most common diseases that seriously endanger human health. Appropriate and effective selection of liver-protecting drugs can not only improve the patient's clinical symptoms and prognosis rapidly, but also lay the foundation for further etiological treatment. In recent years, many new-generation liver-protecting drugs or therapies have been developed at home and abroad, bringing new opportunities for many refractory liver diseases. However, taking many drugs will not only increase the burden on the liver, but also some liver-protecting drugs will accumulate in the body for a long time. It will also cause...

AI Technical Summary

Problems solved by technology

In recent years, many new-generation liver-protecting drugs or therapies have been developed at home and abroad, bringing new opportunities for many refractory liver diseases. However, taking many drugs will not only increase the burden on the liver, but also some liver-protecting drugs will accumulate in the body for a long time. It will also cause damage to the liver, increase the patient's dependence on drugs, and interfere with the treatment and medication of liver diseases